Don Rockey to Clinical Trials as Topic
This is a "connection" page, showing publications Don Rockey has written about Clinical Trials as Topic.
Connection Strength
0.529
-
Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials. Drug Saf. 2021 06; 44(6):619-634.
Score: 0.139
-
Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice. Am J Gastroenterol. 2020 05; 115(5):783-785.
Score: 0.131
-
Gastrointestinal bleeding. Gastroenterol Clin North Am. 2005 Dec; 34(4):581-8.
Score: 0.048
-
Lower gastrointestinal bleeding--management. Gastroenterol Clin North Am. 2005 Dec; 34(4):665-78.
Score: 0.048
-
Obscure gastrointestinal bleeding. Gastroenterol Clin North Am. 2005 Dec; 34(4):679-98.
Score: 0.048
-
Occult gastrointestinal bleeding. Gastroenterol Clin North Am. 2005 Dec; 34(4):699-718.
Score: 0.048
-
Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. Drug Saf. 2021 02; 44(2):133-165.
Score: 0.034
-
The crisis in clinical research. JAMA. 1999 Nov 24; 282(20):1914; author reply 1915-6.
Score: 0.032